Therapeutics: Peroxisome proliferator activated receptor (PPAR) α; PPARγ coactivator 1-α (PPARGC1A, PGC-1a)

Renal

INDICATION: Renal disease

Studies in mice and patient samples suggest stimulating fatty acid oxidation (FAO)

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE